News
CLSN
--
0.00%
--
Celsion Announces Common Stock Purchase Agreement with Lincoln Park Capital and Provides Updates on OVATION 2 Study
GlobeNewswire · 09/08 13:35
Celsion Corporation Restructures Strategic Loan Facility
ompletes New $5 Million Loan Agreement with Market Competitive Terms and Debt Reduction Consistent with Celsion's Capitalization New Agreement Ensures A Strong Balance Sheet and Additional Operating
Benzinga · 09/02 12:07
Celsion Corporation (CLSN) CEO Michael Tardugno on Q2 2020 Results - Earnings Call Transcript
Celsion Corporation (NASDAQ:CLSN) Q2 2020 Results Conference Call August 14, 2020 11:00 AM ET Company Participants Kim Golodetz - IR, LHA Investor Relations Michael Tardugno - Chairman, President and Chief Executive Officer Jeffrey Church - Senior Vice President and Chief Financial Officer Nicholas Borys - Chief Medical Officer Conference Call Participants Justin Kim - Oppenheimer Raj Kumar - Brookline Capital Markets Presentation Operator Good morning.
Seeking Alpha - Transcript · 08/14 20:24
Celsion: Q2 Earnings Insights
Benzinga · 08/14 13:48
Celsion Q2 EPS $(0.18) Misses $(0.14) Estimate, Sales $125.00K Beat $80.00K Estimate
Celsion (NASDAQ:CLSN) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.14) by 28.57 percent. This is a 37.93 percent increase over losses of $(0.29) per share from the
Benzinga · 08/14 12:04
Celsion EPS misses by $0.03, revenue in-line
Celsion (CLSN): Q2 GAAP EPS of -$0.18 misses by $0.03.Revenue of $0.13M in-line (flat Y/Y).Shares +1.83% PM.Press Release
Seekingalpha · 08/14 12:02
Celsion Corporation to Hold Second Quarter 2020 Financial Results and Business Update Conference Call on Friday, August 14, 2020
LAWRENCEVILLE, N.J, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss financial results for the second quarter ended June 30, 2020 and provide an update on its developme
GlobeNewswire · 08/07 12:30
Celsion up 10% on ray of hope for ThermoDox in liver cancer study
Nano cap Celsion (NASDAQ:CLSN) is up 10% premarket on increased volume in reaction to its announcement that will continue following patients for overall su
seekingalpha · 08/04 18:08
Celsion Corporation To Continue Following Patients In Phase III OPTIMA Study For Overall Survival
Ongoing Analysis of Unblinded Study Data Suggests Data Maturity May be at Issue Cohort of 26 Consecutive Patient Deaths Differs Substantially from Predicted Behavior and from the Balance of the Trial LAWRENCEVILLE,
Benzinga · 08/04 12:36
Celsion Corporation to Continue Following Patients in Phase III OPTIMA Study for Overall Survival
Ongoing Analysis of Unblinded Study Data Suggests Data Maturity May be at Issue Cohort of 26 Consecutive Patient Deaths Differs Substantially from Predicted Behavior and from the Balance of the Trial LAWRENCEVILLE, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Celsi
GlobeNewswire · 08/04 12:30
Celsion Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha · 07/28 19:53
Celsion initiates mid-stage GEN-1 study in ovarian cancer
Seeking Alpha · 07/27 14:22
Celsion Corporation Initiates Phase II OVATION 2 Study of GEN-1 in Advanced Ovarian Cancer
Promising Translational and Clinical Findings Support the Randomized Trial in Newly Diagnosed Patients Non-Viral Nanoparticle Delivery System, TheraPlas Platform, Demonstrates Potential for Long-Term, Repeat Administration Up To 6 MonthsLAWRENCEVILLE, N.J.,
GlobeNewswire · 07/27 12:30
Is the Options Market Predicting a Spike in Celsion (CLSN) Stock?
Investors need to pay close attention to Celsion (CLSN) stock based on the movements in the options market lately.
Zacks · 07/21 12:56
Celsion (CLSN) Stock Loses a Wall Street Supporter
Stocks go up, stocks go down, you can't explain that...Or maybe you can, if the stock happen to be a biotech that just flunked a clinical trial. Which leads us nicely to Celsion Corporation (CLSN). Or not so nicely if you happen to be an investor.Shares crater
SmarterAnalyst · 07/18 02:26
64 Biggest Movers From Yesterday
Gainers InnerWorkings, Inc. (NASDAQ: INWK) shares jumped 115.9% to close at $2.85 on Thursday after HH Global announced plans to acquire the company for $3 per share.
Benzinga · 07/17 09:08
Celsion Down on DMC Recommendation to Stop Liver Cancer Study
Celsion (CLSN) plummets on DMC recommendation to stop its phase III study assessing the efficacy of ThermoDox for HCC.
Zacks · 07/14 14:49
Celsion Corporation to Hold Conference Call to Discuss OPTIMA Study on Wednesday, July 15, 2020 at 11:00 a.m. Eastern Time
LAWRENCEVILLE, N.J., July 14, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) will host a conference call and webcast on Wednesday, July 15 at 11:00 a.m. Eastern time to discuss its current observations about the results of the OPTIMA Study and the
GlobeNewswire · 07/14 12:30
80 Biggest Movers From Yesterday
Gainers Equillium, Inc. (NASDAQ: EQ) shares surged 730.7% to close at $26.50 on Monday after the company disclosed that Itolizumab significantly reduced mortality in coronavirus patients, according to a clinical trial conducted in India by its partner Biocon.
Benzinga · 07/14 09:11
Mid-Afternoon Market Update: Dow Jumps 400 Points; Equillium Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 1.55% to 26,475 while the NASDAQ rose 0.72% to 10,693.37. The S&P also rose, gaining 1.03% to 3,217.92.
Benzinga · 07/13 18:31